Portfolio company
Synergia
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops optoelectronic neuromodulation devices for patients requiring vagus nerve stimulation and magnetic resonance imaging compatibility.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neuromodulation
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems to treat patients suffering from chronic neuropathic pain.
NeuroBionics
This company develops flexible bioelectronic fibers for endovascular neuromodulation to treat neurological and peripheral nerve disorders in patients without requiring invasive open-brain surgery.
Nervonik
This company develops miniaturised peripheral nerve stimulation implants and wireless power systems for patients suffering from chronic neuropathic pain.
iVEAcare
The company develops neuromodulation therapies and implantable vagus nerve stimulation devices for patients living with epilepsy and other chronic diseases.
Neurobioniocs
The company develops flexible bioelectronic fibers that deliver neuromodulation therapy through blood vessels for patients with neurological disorders.
Synerkine Pharma
This company develops fusion protein therapeutics to treat chronic pain and peripheral neuropathy for patients with inflammatory and neurodegenerative conditions.
Salvia BioElectronics
This company develops thin bioelectronic implants providing neuromodulation therapy for patients suffering from chronic migraine and other neurological conditions.
Stimvia
Stimvia manufactures non-invasive neuromodulation medical devices for patients with overactive bladder and other chronic neurological disorders.
